Skip to main content

Peer Review reports

From: Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation

Original Submission
26 Jan 2024 Submitted Original manuscript
25 Mar 2024 Reviewed Reviewer Report
9 Apr 2024 Reviewed Reviewer Report
21 Apr 2024 Author responded Author comments - Zerui Yang
Resubmission - Version 2
21 Apr 2024 Submitted Manuscript version 2
1 May 2024 Reviewed Reviewer Report
9 May 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 May 2024 Editorially accepted
23 May 2024 Article published 10.1186/s12906-024-04497-z

You can find further information about peer review here.

Back to article page